Metropolis Healthcare Limited disclosed the outcomes of its Nomination and Remuneration Committee meeting held on Tuesday, August 04, 2026. The meeting commenced at 09:30 AM IST and concluded at 10:45 AM IST.
1. Allotment of Equity Shares under MHL-RSU Plan, 2020
The Committee approved the allotment of 18,700 (Eighteen Thousand Seven Hundred) equity shares at an exercise price of ₹2 per share, aggregating to ₹37,400. The shares were allotted against Restrictive Stock Units (RSUs) vested and exercised by company employees.
Key Details of Allotment:
- Distinctive Number Range: 20,73,68,869 to 20,73,87,568 (both inclusive)
- Total issued shares after allotment: 20,73,87,568
- Total issued share capital after allotment: ₹41,47,75,136
- Lock-in Period: 50% of allotted shares subject to lock-in for 1 year from allotment date (until August 04, 2027)
- Shares rank pari-passu with existing equity shares
Regulatory Approvals:
- BSE In-Principle Approval: DCS/ESOP/IP/RD/037/2026-27 dated April 23, 2026
- NSE In-Principle Approval: NSE/LIST/54376 dated April 23, 2026
- Statement filed with stock exchanges on April 01, 2026
2. Grant of Stock Benefits
The Committee approved new grants under two employee benefit plans:
Metropolis – Restrictive Stock Units Plan, 2025:
- 1,380 (one thousand three hundred eighty) units granted
- Exercise price: Face value of ₹2 per unit
- Vesting period: Minimum 1 year, extendable up to four years
- Exercise period: Within 5 years from vesting date
Metropolis – Employees Stock Options Plan, 2025:
- 20,500 (twenty thousand five hundred) options granted
- Exercise price: ₹436.91 per option
- Vesting period: Minimum 1 year, extendable up to four years
- Exercise period: Within 5 years from vesting date
Both schemes are compliant with SEBI (SBEB) Regulations, 2021.